120 related articles for article (PubMed ID: 12898039)
21. Effect of age on biochemical recurrence after radical prostatectomy.
Ozden C; Aktas BK; Bulut S; Erbay G; Tagci S; Gokkaya CS; Baykam MM; Memis A
Kaohsiung J Med Sci; 2017 Feb; 33(2):91-95. PubMed ID: 28137417
[TBL] [Abstract][Full Text] [Related]
22. The impact of a family history of prostate cancer on the prognosis and features of the disease in Korea: results from a cross-sectional longitudinal pilot study.
Lee KS; Koo KC; Chung BH
Int Urol Nephrol; 2017 Dec; 49(12):2119-2125. PubMed ID: 28905176
[TBL] [Abstract][Full Text] [Related]
23. Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy.
Magheli A; Rais-Bahrami S; Peck HJ; Walsh PC; Epstein JI; Trock BJ; Gonzalgo ML
J Urol; 2007 Oct; 178(4 Pt 1):1311-5. PubMed ID: 17698095
[TBL] [Abstract][Full Text] [Related]
24. Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study.
Steuber T; Budäus L; Walz J; Zorn KC; Schlomm T; Chun F; Ahyai S; Fisch M; Sauter G; Huland H; Graefen M; Haese A
BJU Int; 2011 Jun; 107(11):1755-61. PubMed ID: 20942833
[TBL] [Abstract][Full Text] [Related]
25. PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer.
Roberts SG; Blute ML; Bergstralh EJ; Slezak JM; Zincke H
Mayo Clin Proc; 2001 Jun; 76(6):576-81. PubMed ID: 11393495
[TBL] [Abstract][Full Text] [Related]
26. No Detrimental Effect of a Positive Family History on Long-Term Outcomes Following Radical Prostatectomy.
Brath JM; Grill S; Ankerst DP; Thompson IM; Gschwend JE; Herkommer K
J Urol; 2016 Feb; 195(2):343-8. PubMed ID: 26239337
[TBL] [Abstract][Full Text] [Related]
27. Time trends in case selection, stage and prostate-specific antigen recurrence after radical prostatectomy: a multicentre audit.
Winkler MH; Khan FA; Hoh IM; Okeke AA; Sugiono M; McInerney P; Boustead GB; Persad R; Kaisary AV; Gillatt DA
BJU Int; 2004 Apr; 93(6):725-9. PubMed ID: 15049980
[TBL] [Abstract][Full Text] [Related]
28. Prostate-specific antigen level, stage or Gleason score: which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database.
Mithal P; Howard LE; Aronson WJ; Kane CJ; Cooperberg MR; Terris MK; Amling CL; Freedland SJ
Int J Urol; 2015 Apr; 22(4):362-6. PubMed ID: 25728968
[TBL] [Abstract][Full Text] [Related]
29. Oncologic outcomes at 10 years following robotic radical prostatectomy.
Diaz M; Peabody JO; Kapoor V; Sammon J; Rogers CG; Stricker H; Lane Z; Gupta N; Bhandari M; Menon M
Eur Urol; 2015 Jun; 67(6):1168-1176. PubMed ID: 24996687
[TBL] [Abstract][Full Text] [Related]
30. Familial prostate cancer cases before and after radical prostatectomy do not show any aggressiveness compared with sporadic cases.
Azzouzi AR; Valeri A; Cormier L; Fournier G; Mangin P; Cussenot O
Urology; 2003 Jun; 61(6):1193-7. PubMed ID: 12809896
[TBL] [Abstract][Full Text] [Related]
31. Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens.
Swindle P; Eastham JA; Ohori M; Kattan MW; Wheeler T; Maru N; Slawin K; Scardino PT
J Urol; 2005 Sep; 174(3):903-7. PubMed ID: 16093984
[TBL] [Abstract][Full Text] [Related]
32. Influence of statin use on clinicopathological characteristics of localized prostate cancer and outcomes obtained after radical prostatectomy: a single center study.
Cattarino S; Seisen T; Drouin SJ; Renard-Penna R; Leon P; Comperat E; Mozer P; Cussenot O; Rouprêt M
Can J Urol; 2015 Apr; 22(2):7703-8. PubMed ID: 25891333
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological features of patients with biochemical recurrence after radical prostatectomy without progressive rise in serum prostate-specific antigen.
Miyake H; Hara I; Kurahashi T; Muramaki M; Yamanaka K; Inoue TA; Fujisawa M
Urol Int; 2006; 77(3):200-4. PubMed ID: 17033205
[TBL] [Abstract][Full Text] [Related]
34. Significance of familial history of prostate cancer to traditional prognostic variables, genetic biomarkers, and recurrence after radical prostatectomy.
Bauer JJ; Srivastava S; Connelly RR; Sesterhenn IA; Preston DM; McLeod DG; Moul JW
Urology; 1998 Jun; 51(6):970-6. PubMed ID: 9609635
[TBL] [Abstract][Full Text] [Related]
35. Digital rectal examination is no longer necessary in the routine follow-up of men with undetectable prostate specific antigen after radical prostatectomy: the implications for follow-up.
Chaplin BJ; Wildhagen MF; Schroder FH; Kirkels WJ; Bangma CH
Eur Urol; 2005 Dec; 48(6):906-10. PubMed ID: 16126322
[TBL] [Abstract][Full Text] [Related]
36. Allelic imbalance and biochemical outcome after radical prostatectomy.
Bott SR; Masters JR; Parkinson MC; Kirby RS; Feneley M; Hooper J; Williamson M
Prostate Cancer Prostatic Dis; 2006; 9(2):160-8. PubMed ID: 16534511
[TBL] [Abstract][Full Text] [Related]
37. Prostate cancers of different zonal origin: clinicopathological characteristics and biochemical outcome after radical prostatectomy.
Iremashvili V; Pelaez L; Jordá M; Manoharan M; Rosenberg DL; Soloway MS
Urology; 2012 Nov; 80(5):1063-9. PubMed ID: 23107397
[TBL] [Abstract][Full Text] [Related]
38. Comparison of pathological and biochemical outcomes after radical prostatectomy in Korean patients with serum PSA ranges.
Lee HW; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
J Korean Med Sci; 2015 Mar; 30(3):317-22. PubMed ID: 25729256
[TBL] [Abstract][Full Text] [Related]
39. Testosterone as a predictor of pathological stage in clinically localized prostate cancer.
Isom-Batz G; Bianco FJ; Kattan MW; Mulhall JP; Lilja H; Eastham JA
J Urol; 2005 Jun; 173(6):1935-7. PubMed ID: 15879785
[TBL] [Abstract][Full Text] [Related]
40. Impact of prostate-specific antigen testing on the clinical and pathological outcomes after radical prostatectomy for Gleason 8-10 cancers.
Boorjian SA; Karnes RJ; Rangel LJ; Bergstralh EJ; Frank I; Blute ML
BJU Int; 2008 Feb; 101(3):299-304. PubMed ID: 17922854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
